PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor
Autor: | Jiaqian Lin, Xiaodong Gao, Chen Xu, Kuntang Shen, Qin Hu, Yalan Liu, Yuan Shi, Anwei Xue, Shaohua Lu, Jian-Fang Xu, Yingyong Hou, Yunshan Tan, Xiaojing Li, Dongxian Jiang |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
Male 0301 basic medicine Pathology medicine.medical_specialty Stromal cell Gastrointestinal Stromal Tumors Down-Regulation Antineoplastic Agents Apoptosis Pathology and Forensic Medicine Phosphatidylinositol 3-Kinases 03 medical and health sciences 0302 clinical medicine Cell Line Tumor microRNA Humans Medicine RNA Neoplasm Stromal tumor 3' Untranslated Regions Protein Kinase Inhibitors neoplasms Molecular Biology Aged Cell Proliferation Gastrointestinal Neoplasms Regulation of gene expression business.industry Microarray analysis techniques Cell growth Imatinib Cell Biology Middle Aged Gene Expression Regulation Neoplastic MicroRNAs HEK293 Cells 030104 developmental biology Imatinib mesylate Drug Resistance Neoplasm 030220 oncology & carcinogenesis Imatinib Mesylate Cancer research Female business medicine.drug |
Zdroj: | Laboratory Investigation. 96:652-660 |
ISSN: | 0023-6837 |
DOI: | 10.1038/labinvest.2015.157 |
Popis: | Imatinib mesylate resistance occurs in some patients with gastrointestinal stromal tumors (GISTs) during the course of treatment. In this study, we investigated the relationship between microRNAs (miRNAs) and imatinib-resistant GISTs, and the effect of miR-518a-5p on PIK3C2A in imatinib-resistant GISTs. A total of 20 matched-pair GIST samples from imatinib-resistant patients were included in the study. Each of the paired tumor specimens were from the same patient who had surgical removal of GISTs preimatinib and postimatinib treatment. Seven pairs of tissues were resected for microarray analysis, and the remaining 13 pairs were utilized for miRNAs analysis. Target genes were selected based on bioinformatics from multiple biological databases. Luciferase reporter assays were used to confirm the binding of miR-518a-5p to PIK3C2A 3'UTR. GIST882R-NC, 882R-miR-518a-5p-OE, and 882R-miR-518a-5p-KD cell lines were constructed using lentiviral vectors. miR-518a-5p and PIK3C2A expression in 882R-NC, 882R-OE, and 882R-KD cells was assessed by real-time PCR and western blotting. A cell counting kit was used to detect the influence of miR-518a-5p to cell proliferation. TUNEL staining was applied to detect the influence of miR-518a-5p to cell apoptosis. Microarray analysis showed that miR-518a-5p was downregulated in imatinib-resistant GISTs, and the expression of miR-518a-5p was confirmed with good concordance between real-time PCR and miRNA microarray results. Luciferase reporter assays indicated that miR-518a-5p bound to the PIK3C2A 3'UTR. Compared with 882R-OE, PIK3C2A expression was significantly increased in 882R-KD cells. MiR-518a-5p reduced 882R proliferation and promoted 882R apoptosis. In conclusion, PIK3C2A is a gene-specific target of miR-518a-5p in imatinib mesylate-resistant GISTs. Low expression of miR-518a-5p is likely to upregulate PIK3C2A and affect the cellular response to the drug, causing resistance to imatinib in GISTs. |
Databáze: | OpenAIRE |
Externí odkaz: |